Skip to content

Adolescent Exposure to a THC-Rich Cannabis Extract Produces Genotype-Dependent Effects on Cognition and Glial Morphology in Serine Racemase Mutant Mice.

Igor F Rangel, Melissa Chaves, Iohanna Pagnoncelli, Isabelle Medeiros, Felipe Pinheiro, Lorena Fortuna, Luiza Castello-Branco, Ernesto Diaz Roch, Virgínia Martins Carvalho, Flavia Regina Souza Lima, Rogério Panizzutti, Luciana Romão

Journal of Neurochemistry September 2026 DOI: 10.1111/jnc.70559 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Controlled animal experimental study Peer reviewed
Population SrrY269* serine racemase mutant mice and wild-type mice exposed to a THC-rich cannabis extract during adolescence
Intervention THC-rich cannabis extract
Dose escalating oral doses
Duration Exposure during adolescence with evaluation in adulthood
Measures prepulse inhibition, spatial object recognition memory, open field test, amino acid quantification, glial morphometric analyses
Topics Cannabis
Keywords D‐serine Astrocytes Cannabinoids Microglia Neuroinflammation Schizophrenia Serine racemase
Key findings Adolescent exposure to a THC-rich cannabis extract prevented prepulse inhibition and spatial object recognition deficits and attenuated microglial and astrocytic alterations in adult SrrY269* mice, while transiently impairing sensorimotor gating and inducing a distinct astrocytic phenotype in wild-type mice. The authors argue that genetic background may be an important determinant of the long-term neurodevelopmental consequences of adolescent THC-rich cannabis exposure.

Abstract

Adolescent cannabis exposure has been associated with an increased risk of schizophrenia; however, how genetic vulnerability shapes the long-term consequences of adolescent cannabinoid exposure remains poorly understood. Δ9-Tetrahydrocannabinol (THC), the principal psychoactive constituent of cannabis and the predominant cannabinoid in the THC-rich cannabis extract used here, primarily activates cannabinoid type 1 receptors (CB1). In parallel, reduced availability of D-serine, an endogenous co-agonist of N-methyl-D-aspartate receptors (NMDARs), has been implicated in the pathophysiology of schizophrenia. Here, we investigated whether adolescent exposure to a THC-rich cannabis extract modulated long-term behavioral, neurochemical, and glial outcomes in serine racemase mutant (SrrY269*) mice, a genetic model characterized by reduced D-serine levels and schizophrenia-relevant phenotypes. Mice received escalating oral doses of the THC-rich cannabis extract during adolescence and were evaluated in adulthood using behavioral assays, amino acid quantification, and glial morphometric analyses. Adolescent exposure to the THC-rich cannabis extract prevented deficits in prepulse inhibition and spatial object recognition memory in adult SrrY269* mice, while transiently impairing sensorimotor gating in wild-type animals. Irrespective of genotype, mice exposed to the THC-rich cannabis extract spent more time in the center of the open field in adulthood. In behaviorally tested SrrY269* mice, reduced hippocampal microglial branching was attenuated following adolescent treatment. In an independent behavior-naïve cohort, SrrY269* mice exhibited marked astrocytic morphological alterations, several of which were also attenuated by adolescent exposure to the THC-rich cannabis extract. In contrast, the same treatment induced a distinct astrocytic phenotype in wild-type mice. Adolescent exposure to the THC-rich cannabis extract did not alter hippocampal or prefrontal cortical levels of D-serine or other amino acids involved in NMDAR signaling in adulthood. These findings indicate that adolescent exposure to a THC-rich cannabis extract produces genotype-dependent long-term effects, preventing specific behavioral deficits and attenuating independently assessed microglial and astrocytic alterations in SrrY269* mice, while producing adverse behavioral and astrocytic outcomes in wild-type animals. Genetic background may therefore be an important determinant of the long-term neurodevelopmental consequences of adolescent exposure to THC-rich cannabis extracts.

Comparable studies

Other preclinical and animal studies on cannabis, most cited first.

Study Year Design Participants
Cognitive Impairment Induced by Delta9-tetrahydrocannabinol Occurs through Heteromers between Cannabinoid CB1 and Serotonin 5-HT2A Receptors Mice 2015 Preclinical study
Interaction of drugs of abuse and maintenance treatments with human P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2). hMDR1- and hBCRP-transfected HEK293 cells and hMDR1- and hBCRP-MDCKII cells 2010 In vitro study
Long-term hippocampal interneuronopathy drives sex-dimorphic spatial memory impairment induced by prenatal THC exposure Mice prenatally exposed to THC, including conditional CB1R knockout mice 2020 Animal experimental study
Chronic cannabis promotes pro-hallucinogenic signaling of 5-HT2A receptors through Akt/mTOR pathway Mice exposed to chronic THC early in life 2018 Animal experimental study
Effects of cannabinoid drugs on the deficit of prepulse inhibition of startle in an animal model of schizophrenia: the SHR strain Spontaneously hypertensive rats (SHRs) and Wistar rats 2014 Animal experimental study

Citations in the library

Explore topics